Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform.
Synuclein gamma (SNCG) is under consideration as a potential biomarker in cancer biology. Up to date four different SNCG variants are described. Due to growing evidence suggesting correlations between aberrant alternative splicing processes and cancer progression, we investigated the effects of peritumoural conditions on expression pattern of SNCG in endometrial cancer (EC) in vitro. Compared to breast cancer cell lines, mRNA expression levels of all known SNCG isoforms 1-4 are significantly reduced in EC cell lines. We identified a novel alternatively spliced variant of isoform 2 (isoform 2 short) which is found highly expressed in EC cell lines. Hypoxia and acidosis trigger an up-regulation of isoform 2 short. EC cell lines are characterized by low SNCG protein levels under control conditions, but exhibit a significant increase triggered by hypoxia and acidosis. In addition we analysed the potential association between SNCG protein expression and clinico-pathological parameters in human EC samples. Our findings indicate a grade-dependent induction of SNCG protein expression in endometrial cancer. We identified for the first time a novel isoform of SNCG that is found specifically expressed in EC. Our results also strongly indicate the existence of a corresponding protein of isoform 2 short that potentially plays a critical role in EC cancer progression.
Department of Obstetrics and Gynecology, University Medical Center, Freiburg, Germany.|Department of Urology, University Medical Center, Freiburg, Germany.
Kathrin
K
Schaal
Department of Obstetrics and Gynecology, University Medical Center, Freiburg, Germany.|German Cancer Consortium (DKTK), Freiburg, Germany.|German Cancer Research Center (DKZF), Heidelberg, Germany.
Marc
M
Hirschfeld
German Cancer Consortium (DKTK), Freiburg, Germany.|German Cancer Research Center (DKZF), Heidelberg, Germany.|Institute of Surgical Pathology, University Medical Center, Freiburg, Germany.|Comprehensive Cancer Center, University Medical Center, Freiburg, Germany.
Peter
P
Bronsert
Institute of Surgical Pathology, University Medical Center, Freiburg, Germany.|Comprehensive Cancer Center, University Medical Center, Freiburg, Germany.
Hannah
H
Füllgraf
Department of Obstetrics and Gynecology, University Medical Center, Freiburg, Germany.
Markus
M
Jäger
Institute of Surgical Pathology, University Medical Center, Freiburg, Germany.
Bettina
B
Herde
Department of Obstetrics and Gynecology, University Medical Center, Freiburg, Germany.
Claudia
C
Nöthling
Department of Obstetrics and Gynecology, University Medical Center, Freiburg, Germany.
Sebastian
S
Mayer
Department of Obstetrics and Gynecology, University Medical Center, Freiburg, Germany.
Thalia
T
Erbes
Department of Obstetrics and Gynecology, University Medical Center, Freiburg, Germany.|German Cancer Consortium (DKTK), Freiburg, Germany.|German Cancer Research Center (DKZF), Heidelberg, Germany.|Comprehensive Cancer Center, University Medical Center, Freiburg, Germany.
Elmar
E
Stickeler
D017398:Alternative Splicing; D000595:Amino Acid Sequence; D014408:Biomarkers, Tumor / Q000235:genetics; D016889:Endometrial Neoplasms / Q000235:genetics*; D005260:Female; D006801:Humans; D008969:Molecular Sequence Data; D009363:Neoplasm Proteins / Q000235:genetics*; D020033:Protein Isoforms; D051845:gamma-Synuclein / Q000235:genetics*
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D020033:Protein Isoforms; D051845:gamma-Synuclein
SNCG; alternative splicing; biomarker; endometrial cancer; synuclein gamma